Pharma Focus Asia

FUJIFILM Diosynth Biotechnologies Opens State-of-the-Art Cell Culture Process Development Laboratories in Teesside

Introduction:

FUJIFILM Diosynth Biotechnologies has announced the opening of the 10,000 square foot, state-of-the-art cell culture Process Development Laboratories in Wilton Centre, Teesside.

Features:

The opening of these laboratories was made with a $9M USD investment which is part of the greater $130M USD expansion.

The new facility will bring new sustainable, high tech jobs to the region. Let’s Grow, a part of The Regional Growth Fund also contributed to the overall investment as part of FUJIFILM Diosynth Biotechnologies’.

This helps to continue growth in the Tees Valley. FUJIFILM is planning to continue to be at the forefront of pioneering research and the destination of choice for inward investment.

The new laboratories will be dedicated to support the Saturn™ mAb Platform cell culture Process Development activities.

The Saturn mAb Platform™ is designed to enable rapid access to process development and manufacturing capacity.

To incorporate the latest high-throughput technologies including fully automated high throughput bioreactors and chromatography systems, these laboratories are designed.

The Saturn™ Process Development Laboratories are a huge differentiator in the cell culture and monoclonal antibody process development space.

FUJIFILM helps patients in the rapid delivery of monoclonal antibody therapies by dedicating these facilities and bringing new technologies.

Specifications:

NameFUJIFILM Diosynth Biotechnologies
LocationTexas, USA
TypeOpening
Parties InvolvedFUJIFILM Diosynth Biotechnologies
Budget$9M USD
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference